In this analysis, PPARγ expression was dramatically reduced within the vasculature associated with DCIS lesions and IBC (Fig. 4 D and E, and SI Appendix, Fig. S12), suggesting that reduced expression of PPARγ itself determined the loss of target gene expression, including CD36 (Fig. 4F). This evidence concerns the gene PPARG and inflammatory breast carcinoma.